We are live on ! Find out more
WX

WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS
WX

Delisted

WX was delisted on the 10th of December, 2015.

Back to rankings

132 hedge funds and large institutions have $1.63B invested in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in 2013 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 34 increasing their positions, 58 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,556% more call options, than puts

Call options by funds: $425K | Put options by funds: $16K

263% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 8

200% more funds holding in top 10

Funds holding in top 10: 2 → 6 (+4)

29% more capital invested

Capital invested by funds: $1.26B → $1.63B (+$370M)

17% more funds holding

Funds holding: 113 → 132 (+19)

41% less repeat investments, than reductions

Existing positions increased: 34 | Existing positions reduced: 58

Holders
132
Holders Change
+19
Holders Change %
+16.81%
% of All Funds
4.28%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.19%
New
29
Increased
34
Reduced
58
Closed
8
Calls
$425K
Puts
$16K
Net Calls
+$409K
Net Calls Change
+$362K

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$23.7M
2
Ameriprise
Ameriprise
Minnesota
+$17.8M
3
CCAM
Coupland Cardiff Asset Management
United Kingdom
+$11.5M
4
SR
Sloane Robinson
United Kingdom
+$7.18M
5
Ninety One (UK)
Ninety One (UK)
United Kingdom
+$7.03M

Top Sellers

Rank Fund Capital Flow
1
BTP
Bloom Tree Partners
New York
-$10.9M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$8.62M
3
Schroder Investment Management Group
Schroder Investment Management Group
United Kingdom
-$8.54M
4
Wellington Management Group
Wellington Management Group
Massachusetts
-$8.02M
5
BG
BlackRock Group
United Kingdom
-$7.74M
Name Holding Trade Value Shares
Change 		Change in
Stake
MICM
51
Matthews International Capital Management
California
$4.23M +$175K +7,400 +5%
Two Sigma Investments
52
Two Sigma Investments
New York
$3.72M -$3.09M -130,413 -49%
WHG
53
Westwood Holdings Group
Texas
$3.65M -$30.5K -1,289 -1%
Millennium Management
54
Millennium Management
New York
$3.42M -$522K -22,036 -15%
Wells Fargo
55
Wells Fargo
California
$3.41M -$308K -12,989 -9%
GC
56
Guggenheim Capital
Illinois
$3.35M -$139K -5,870 -5%
MAA
57
Managed Account Advisors
New Jersey
$2.95M -$189K -7,990 -7%
CCM
58
Causeway Capital Management
California
$2.92M +$2.53M +106,600 New
Morgan Stanley
59
Morgan Stanley
New York
$2.65M -$58.1K -2,453 -2%
Renaissance Technologies
60
Renaissance Technologies
New York
$2.61M +$1.56M +65,700 +223%
RSS
61
Rosenblum Silverman Sutton
California
$2.49M +$2.15M +90,810 New
NFA
62
Nationwide Fund Advisors
Ohio
$2.44M -$1.03M -43,430 -33%
U
63
UBS
Switzerland
$2.38M +$62K +2,615 +3%
GI
64
GAMCO Investors
Connecticut
$2.37M -$723K -30,500 -26%
Credit Agricole
65
Credit Agricole
France
$2.35M +$2.03M +85,819 New
Deutsche Bank
66
Deutsche Bank
Germany
$2.23M -$150K -6,334 -7%
ACM
67
Apex Capital Management
Ohio
$2.2M +$1.9M +80,238 New
SCA
68
SAC Capital Advisors
Connecticut
$1.83M -$2.02M -85,106 -56%
GT
69
Glenmede Trust
Pennsylvania
$1.76M – – –
MIP
70
Marietta Investment Partners
Wisconsin
$1.62M +$1,000K +42,188 +247%
UBS AM
71
UBS AM
Illinois
$1.48M -$82.9K -3,500 -6%
KCM
72
Kornitzer Capital Management
Kansas
$1.47M +$701K +29,600 +123%
GH
73
GAM Holding
Switzerland
$1.47M – – –
OAM
74
Origin Asset Management
United Kingdom
$1.41M +$1.22M +51,450 New
ACI
75
AMP Capital Investors
Australia
$1.38M -$372K -15,700 -24%
1 2
3
4 5

WX Hedge Fund Activity: Q3 2013 in Review

132 of the 3,084 institutional investors tracked by Wall St. Rank reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) for Q3 2013, worth a combined $1.63B — up 29% from $1.26B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new WX positions and 8 closed out — a net gain of 21 holders — while 34 added to existing stakes and 58 trimmed.

The largest buyer was Consonance Capital Management, opening a new position worth an estimated $23.7M. The largest seller was Bloom Tree Partners, exiting entirely with an estimated $10.9M sold.

  • 132 institutional investors held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) as of Q3 2013, up from 113 in Q2 2013.
  • Funds reported $1.63B of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS stock for Q3 2013, up 29% quarter-over-quarter.
  • 29 funds opened new WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS positions in Q3 2013 and 8 closed out, a net change of +21 holders.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS buyer in Q3 2013 was Consonance Capital Management, an estimated $23.7M added.
  • The largest WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS seller in Q3 2013 was Bloom Tree Partners, an estimated $10.9M sold.

Based on aggregated 13F filings for Q3 2013.